mutLBSgeneDB |
Gene summary for ZNF224 |
Gene summary |
Basic gene Info. | Gene symbol | ZNF224 |
Gene name | zinc finger protein 224 | |
Synonyms | BMZF-2|BMZF2|KOX22|ZNF255|ZNF27 | |
Cytomap | UCSC genome browser: 19q13.2 | |
Type of gene | protein-coding | |
RefGenes | NM_013398.2, | |
Description | bone marrow zinc finger 2zinc finger 2, bone marrowzinc finger protein 233zinc finger protein 255zinc finger protein 27 (KOX 22)zinc finger protein KOX22zinc finger protein ZNF255 | |
Modification date | 20141207 | |
dbXrefs | MIM : 194555 | |
HGNC : HGNC | ||
Ensembl : ENSG00000267680 | ||
HPRD : 06094 | ||
Vega : OTTHUMG00000182313 | ||
Protein | UniProt: Q9NZL3 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ZNF224 | |
BioGPS: 7767 | ||
Pathway | NCI Pathway Interaction Database: ZNF224 | |
KEGG: ZNF224 | ||
REACTOME: ZNF224 | ||
Pathway Commons: ZNF224 | ||
Context | iHOP: ZNF224 | |
ligand binding site mutation search in PubMed: ZNF224 | ||
UCL Cancer Institute: ZNF224 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0045892 | negative regulation of transcription, DNA-templated | 20587513 |
Top |
Ligand binding site mutations for ZNF224 |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | H698 | R696Q | COAD | 2 | C654 | E655K | BLCA | 1 | C206 | Y204C | KIRC | 1 | C318 | D319H | LUAD | 1 | H194 | H194Y | SKCM | 1 | H194 | R192C | SKCM | 1 | H226 | V225A | STAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for ZNF224 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | C206 | Y204C | -1.5255933 | H226 | V225A | -1.3338292 | C654 | E655K | -1.3264279 | H698 | R696Q | -1.0490232 | C318 | D319H | -1.0056105 | H194 | H194Y | -0.60772944 | H194 | R192C | -0.48077577 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for ZNF224 from PDB |
PDB ID | PDB title | PDB structure | 2ELY | Solution structure of the third zf-C2H2 domain from human Zinc finger protein 224 |
Top |
Differential gene expression and gene-gene network for ZNF224 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for ZNF224 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for ZNF224 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of ZNF224 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of ZNF224 |
Multiple alignments for Q9NZL3 in multiple species |
LBS | AA sequence | # species | Species |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |